These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 30267712)

  • 21. Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections.
    Ferrari C; Penna A; Bertoletti A; Cavalli A; Missale G; Lamonaca V; Boni C; Valli A; Bertoni R; Urbani S; Scognamiglio P; Fiaccadori F
    Recent Results Cancer Res; 1998; 154():330-6. PubMed ID: 10027013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunology of hepatitis B and hepatitis C virus infections.
    Boonstra A; Woltman AM; Janssen HL
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1049-61. PubMed ID: 19187866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver.
    Suslov A; Boldanova T; Wang X; Wieland S; Heim MH
    Gastroenterology; 2018 May; 154(6):1778-1790. PubMed ID: 29408639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
    Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
    Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F
    J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection.
    Degasperi E; Caprioli F; El Sherif O; Back D; Colombo M; Aghemo A
    Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1373-1383. PubMed ID: 27718758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innate and Adaptive Immune Responses in Chronic HCV Infection.
    Dustin LB
    Curr Drug Targets; 2017; 18(7):826-843. PubMed ID: 26302811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate detection of hepatitis B and C virus and viral inhibition of the response.
    Yi Z; Chen J; Kozlowski M; Yuan Z
    Cell Microbiol; 2015 Sep; 17(9):1295-303. PubMed ID: 26243406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The Past and Future of Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Infection].
    Hayashi J
    Rinsho Byori; 2015 Jun; 63(6):746-7. PubMed ID: 26548239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
    Liu CJ
    J Gastroenterol Hepatol; 2014 Jan; 29(1):26-30. PubMed ID: 24199625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B and hepatitis C in 2009.
    Marcellin P
    Liver Int; 2009 Jan; 29 Suppl 1():1-8. PubMed ID: 19207959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBV and the immune response.
    Ferrari C
    Liver Int; 2015 Jan; 35 Suppl 1():121-8. PubMed ID: 25529097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early detection of unhealthy behaviors, the prevalence and receipt of antiviral treatment for disabled adult hepatitis B and C carriers.
    Jane SW; Lin MS; Chiu WN; Lai LJ; Chen PH; Chen MY
    BMC Public Health; 2016 Feb; 16():146. PubMed ID: 26873327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence.
    Biliotti E; Zacharia S; Grieco S; Spaziante M; Giusto M; Merli M; Gallinaro V; Taliani G
    J Chemother; 2012 Dec; 24(6):369-72. PubMed ID: 23174103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
    Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
    Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of hepatitis B virus infection.
    Baumert TF; Thimme R; von Weizsäcker F
    World J Gastroenterol; 2007 Jan; 13(1):82-90. PubMed ID: 17206757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection.
    Zhang Z; Zhang JY; Wang LF; Wang FS
    J Gastroenterol Hepatol; 2012 Feb; 27(2):223-30. PubMed ID: 22004062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of human immunodeficiency virus on viral hepatitis.
    Mallet V; Vallet-Pichard A; Pol S
    Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection.
    Gehring AJ; Protzer U
    Gastroenterology; 2019 Jan; 156(2):325-337. PubMed ID: 30367834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.